160 related articles for article (PubMed ID: 2547415)
21. Amplification of epidermal growth factor receptor (EGFR) gene and oncogenes in human gastric carcinomas.
Yoshida K; Tsuda T; Matsumura T; Tsujino T; Hattori T; Ito H; Tahara E
Virchows Arch B Cell Pathol Incl Mol Pathol; 1989; 57(5):285-90. PubMed ID: 2570489
[TBL] [Abstract][Full Text] [Related]
22. Protooncogene expression in normal, preleukemic, and leukemic murine erythroid cells and its relationship to differentiation and proliferation.
Robert-Lézénès J; Meneceur P; Ray D; Moreau-Gachelin F
Cancer Res; 1988 Jul; 48(14):3972-6. PubMed ID: 3164254
[TBL] [Abstract][Full Text] [Related]
23. Alterations of K-ras, p53, and erbB-2/neu in human lung adenocarcinomas.
Bongiorno PF; Whyte RI; Lesser EJ; Moore JH; Orringer MB; Beer DG
J Thorac Cardiovasc Surg; 1994 Feb; 107(2):590-5. PubMed ID: 7905543
[TBL] [Abstract][Full Text] [Related]
24. Activation of protooncogenes in mouse lung tumors.
You M; Wang Y; Lineen A; Stoner GD; You LA; Maronpot RR; Anderson MW
Exp Lung Res; 1991; 17(2):389-400. PubMed ID: 2050038
[TBL] [Abstract][Full Text] [Related]
25. Mutations of K-ras oncogene and absence of H-ras mutations in squamous cell carcinomas of the lung.
Vachtenheim J; Horáková I; Novotná H; Opáalka P; Roubková H
Clin Cancer Res; 1995 Mar; 1(3):359-65. PubMed ID: 9815992
[TBL] [Abstract][Full Text] [Related]
26. Activation of protooncogenes in spontaneously occurring non-liver tumors from C57BL/6 x C3H F1 mice.
Candrian U; You M; Goodrow T; Maronpot RR; Reynolds SH; Anderson MW
Cancer Res; 1991 Feb; 51(4):1148-53. PubMed ID: 1997158
[TBL] [Abstract][Full Text] [Related]
27. Oncogene amplification in squamous cell carcinoma of the oral cavity.
Saranath D; Panchal RG; Nair R; Mehta AR; Sanghavi V; Sumegi J; Klein G; Deo MG
Jpn J Cancer Res; 1989 May; 80(5):430-7. PubMed ID: 2502519
[TBL] [Abstract][Full Text] [Related]
28. Amplification and enhanced expression of cellular oncogene c-Ki-ras-2 in a human epidermoid carcinoma of the lung.
Miyaki M; Sato C; Matsui T; Koike M; Mori T; Kosaki G; Takai S; Tonomura A; Tsuchida N
Jpn J Cancer Res; 1985 Apr; 76(4):260-5. PubMed ID: 3924699
[TBL] [Abstract][Full Text] [Related]
29. Analysis of the activation of the myc family oncogene and of its stability over time in xenografted human lung carcinomas.
Gazzeri S; Brambilla E; Chauvin C; Jacrot M; Benabid AL; Brambilla C
Cancer Res; 1990 Mar; 50(5):1566-70. PubMed ID: 2154327
[TBL] [Abstract][Full Text] [Related]
30. Enhanced expression of c-myc and epidermal growth factor receptor (C-erbB-1) genes in primary human renal cancer.
Yao M; Shuin T; Misaki H; Kubota Y
Cancer Res; 1988 Dec; 48(23):6753-7. PubMed ID: 2460228
[TBL] [Abstract][Full Text] [Related]
31. Frequent amplification of the bcl-1 locus in poorly differentiated squamous cell carcinoma of the lung. The Lung Cancer Study Group.
Berenson JR; Koga H; Yang J; Pearl J; Holmes EC; Figlin R
Oncogene; 1990 Sep; 5(9):1343-8. PubMed ID: 2170896
[TBL] [Abstract][Full Text] [Related]
32. Heterogeneous protooncogene amplification correlates with tumor progression and presence of metastases in gastric cancer patients.
Ranzani GN; Pellegata NS; Previderè C; Saragoni A; Vio A; Maltoni M; Amadori D
Cancer Res; 1990 Dec; 50(24):7811-4. PubMed ID: 2253224
[TBL] [Abstract][Full Text] [Related]
33. Alterations to either c-erbB-2(neu) or c-myc proto-oncogenes in breast carcinomas correlate with poor short-term prognosis.
Varley JM; Swallow JE; Brammar WJ; Whittaker JL; Walker RA
Oncogene; 1987; 1(4):423-30. PubMed ID: 3330785
[TBL] [Abstract][Full Text] [Related]
34. A novel combination of K-ras and myc amplification accompanied by point mutational activation of K-ras in a human lung cancer.
Taya Y; Hosogai K; Hirohashi S; Shimosato Y; Tsuchiya R; Tsuchida N; Fushimi M; Sekiya T; Nishimura S
EMBO J; 1984 Dec; 3(12):2943-6. PubMed ID: 6098458
[TBL] [Abstract][Full Text] [Related]
35. Amplification of the c-myc oncogene in non-small cell lung cancer.
Ozkara HA; Ozkara S; Topçu S; Criss WE
Tumori; 1999; 85(6):508-11. PubMed ID: 10774575
[TBL] [Abstract][Full Text] [Related]
36. Lack of prognostic implications of HER-2/neu abnormalities in 345 stage I non-small cell carcinomas (NSCLC) and 207 stage I-III neuroendocrine tumours (NET) of the lung.
Pelosi G; Del Curto B; Dell'Orto P; Pasini F; Veronesi G; Spaggiari L; Maisonneuve P; Iannucci A; Terzi A; Lonardoni A; Viale G
Int J Cancer; 2005 Jan; 113(1):101-8. PubMed ID: 15386424
[TBL] [Abstract][Full Text] [Related]
37. Overexpression of oncoproteins in non-small cell lung carcinomas of smokers.
Wodrich W; Volm M
Carcinogenesis; 1993 Jun; 14(6):1121-4. PubMed ID: 8389672
[TBL] [Abstract][Full Text] [Related]
38. Amplification of oncogenes in lung carcinoma grafted in nude mice.
Chauvin C; Jacrot M; Riondel J; Brambilla E; Foote AM; Brambilla C; Benabid AL
Anticancer Res; 1989; 9(2):449-52. PubMed ID: 2568771
[TBL] [Abstract][Full Text] [Related]
39. Specificity of proto-oncogene amplification in human malignant diseases.
Masuda H; Battifora H; Yokota J; Meltzer S; Cline MJ
Mol Biol Med; 1987 Aug; 4(4):213-27. PubMed ID: 3670047
[TBL] [Abstract][Full Text] [Related]
40. Incidence and possible clinical significance of K-ras oncogene activation in adenocarcinoma of the human lung.
Rodenhuis S; Slebos RJ; Boot AJ; Evers SG; Mooi WJ; Wagenaar SS; van Bodegom PC; Bos JL
Cancer Res; 1988 Oct; 48(20):5738-41. PubMed ID: 3048648
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]